| 2017-06-22 | Sale | Regeneron Pharmaceuticals, Inc. REGN | SVP Strategy Investor Relation | 2,269 0.0022% | $532.42 | $1.21M | -27.5% | |
| 2015-03-24 | Sale | Regeneron Pharmaceuticals, Inc. REGN | SVP Strategy Investor Relation | 4,843 0.0048% | $478.99 | $2.32M | +8.14% | |
| 2015-03-18 | Sale | Regeneron Pharmaceuticals, Inc. REGN | SVP Strategy Investor Relation | 3,442 0.0033% | $465.00 | $1.6M | +8.52% | |
| 2015-02-24 | Sale | Regeneron Pharmaceuticals, Inc. REGN | SVP Strategy Investor Relation | 3,374 0.0033% | $418.48 | $1.41M | +21.82% | |
| 2015-02-17 | Sale | Regeneron Pharmaceuticals, Inc. REGN | SVP Strategy Investor Relation | 3,692 0.0036% | $404.46 | $1.49M | +26.79% | |
| 2014-08-19 | Sale | Regeneron Pharmaceuticals, Inc. REGN | VP Strategy and Investor Relat | 3,611 0.0036% | $350.00 | $1.26M | +22.04% | |
| 2014-02-18 | Sale | Regeneron Pharmaceuticals, Inc. REGN | VP Strategy and Investor Relat | 3,648 0.0037% | $331.42 | $1.21M | +3.16% | |
| 2013-05-14 | Sale | Regeneron Pharmaceuticals, Inc. REGN | VP Strategy and Investor Relat | 5,529 0.0056% | $279.61 | $1.55M | -0.17% | |
| 2013-05-06 | Sale | Regeneron Pharmaceuticals, Inc. REGN | VP Strategy and Investor Relat | 8,334 0.0083% | $257.13 | $2.14M | +7.16% | |
| 2012-12-11 | Sale | Regeneron Pharmaceuticals, Inc. REGN | VP Strategy and Investor Relat | 3,368 0.0035% | $185.06 | $623,268 | +30.22% | |
| 2012-11-30 | Sale | Regeneron Pharmaceuticals, Inc. REGN | VP Strategy and Investor Relat | 3,904 0.0042% | $180.64 | $705,228 | +34.07% | |
| 2012-05-01 | Sale | Regeneron Pharmaceuticals, Inc. REGN | VP Strategy and Investor Relat | 6,162 0.0065% | $134.81 | $830,683 | +15.24% | |
| 2011-09-07 | Sale | Regeneron Pharmaceuticals, Inc. REGN | VP Strategy and Investor Relat | 3,377 0.0036% | $69.66 | $235,256 | +54.55% | |
| 2011-09-02 | Sale | Regeneron Pharmaceuticals, Inc. REGN | VP Strategy and Investor Relat | 4,166 0.0045% | $64.00 | $266,624 | +67.81% |